Merck Expands Protein A Capabilities with JSR Chromatography Acquisition - Takeaway - MDSpire
Business Management

Merck Expands Protein A Capabilities with JSR Chromatography Acquisition

The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.

  • April 16, 2026

  • 1 min

Share

  • 1

    Merck acquired chromatography business from JSR Life Sciences.

  • 2

    Amsphere Protein A resins added to portfolio.

  • 3

    Enhances capabilities in monoclonal antibody manufacturing.

  • 4

    Over 50 employees and expertise from Belgium included.

  • 5

    Focus on efficient Protein A capture for productivity.

  • 6

    Aims to meet customer demand for faster biologics production.

  • 7

    Supports process development to commercial production integration.

Original Source(s)

Merck Expands Protein A Capabilities with JSR Chromatography Acquisition

  • April 16, 2026